Agile Therapeutics (AGRX)
OTHER OTC:AGRX
US Market
Holding AGRX?
Track your performance easily

Agile Therapeutics (AGRX) Technical Analysis

1,501 Followers

Technical Sentiment

Overall Consensus
Buy
16Bullish
0Neutral
6Bearish
Technical Analysis Consensus
Sell
4Bullish
0Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Agile Therapeutics’s (AGRX) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Agile Therapeutics is a Buy.
Agile Therapeutics’s (AGRX) 20-Day exponential moving average is 1.46, while Agile Therapeutics’s (AGRX) share price is $1.51, making it a Buy.
Agile Therapeutics’s (AGRX) 50-Day exponential moving average is 1.27, while Agile Therapeutics’s (AGRX) share price is $1.51, making it a Buy.

Agile Therapeutics (AGRX) Pivot Points

Nov 10, 2024, 03:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.49
1.49
1.50
1.51
1.52
1.52
1.53
Fibonacci
1.49
1.50
1.50
1.51
1.51
1.52
1.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agile Therapeutics (AGRX) Moving Averages

Nov 10, 2024, 03:15 AM
Period
Simple
Exponential
MA5
1.49Buy
1.50Buy
MA10
1.47Buy
1.48Buy
MA20
1.47Buy
1.46Buy
MA50
1.29Buy
1.27Buy
MA100
0.84Buy
1.11Buy
MA200
1.14Buy
1.32Buy
Agile Therapeutics’s (AGRX) 10-Day exponential moving average is 1.48, while Agile Therapeutics’s (AGRX) share price is $1.51, making it a Buy.
Agile Therapeutics’s (AGRX) 100-Day exponential moving average is 1.11, while Agile Therapeutics’s (AGRX) share price is $1.51, making it a Buy.
Agile Therapeutics’s (AGRX) stock price is $1.51 and Agile Therapeutics’s (AGRX) 50-day simple moving average is 1.29, creating a Buy signal.
Agile Therapeutics’s (AGRX) stock price is $1.51 and Agile Therapeutics’s (AGRX) 100-day simple moving average is 0.84, creating a Buy signal.
Agile Therapeutics’s (AGRX) stock price is $1.51 and Agile Therapeutics’s (AGRX) 200-day simple moving average is 1.14, creating a Buy signal.

Agile Therapeutics (AGRX) Technical Indicators

Nov 10, 2024, 03:15 AM
Name
Value
Implied Action
RSI (14)
84.74
Sell
STOCH (9,6)
87.50
Sell
STOCHRSI (14)
87.50
Sell
MACD (12,26)
0.05
Buy
ADX (14)
65.52
Sell
Williams %R
-12.50
Sell
CCI (14)
230.01
Sell
ATR (14)
0.02
-
Ultimate Oscillator
73.47
Buy
ROC
3.42
Buy
Agile Therapeutics’s (AGRX) Relative Strength Index (RSI) is 84.74, creating a Sell signal.
Agile Therapeutics’s (AGRX) Trend Strength Indicator (ADX) is 65.52, creating a Sell signal.
Agile Therapeutics’s (AGRX) Commodity Channel Index (CCI) is 230.01, creating a Sell signal.
Agile Therapeutics’s (AGRX) Price Rate of Change (ROC) is 3.42, creating a Buy signal.

FAQ

Is AGRX a Buy, Hold, or Sell?
Based on AGRX’s technical indicators, AGRX is a Buy.
    What is AGRX’s RSI (14)?
    AGRX’s RSI (14) is 84.74, which suggests AGRX is a Sell.
      What is AGRX’s MACD?
      AGRX’s MACD is 0.05, which suggests AGRX is a Buy.
        What is AGRX’s 5-day moving average?
        AGRX’s 5-day moving average is 1.49, which suggests AGRX is a Buy.
          What is AGRX’s 20-day moving average?
          AGRX 20-day moving average is 1.47, which suggests AGRX is a Buy.
            What is AGRX’s 50-day moving average?
            AGRX’s 50-day moving average is 1.29, which suggests AGRX is a Buy.
              What is AGRX’s 200-day moving average?
              AGRX’s 200-day moving average is 1.14, which suggests AGRX is a Buy.
                What is AGRX’s Williams % R (14)?
                AGRX’s Williams % R (14) is -12.50, which suggests AGRX is a Sell.
                  What is AGRX’s CCI (14)?
                  AGRX’s CCI (14) is 230.01, which suggests AGRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis